Genomma Lab Internacional, S.A.B. de C.V. will report its third-quarter 2026 earnings after the Mexican Stock Exchange closes on Wednesday, October 21, 2026. The company will hold a conference call the following day at 11 a.m. Mexico City time, featuring Chief Executive Officer Marco Sparvieri, Chief Financial Officer Antonio Zamora and Investor Relations Officer ChristianneIbanez. Investors can register through a direct webcast link and will receive an email invitation. Genomma Lab, listed on the Mexican Stock Exchange under LAB B and Bloomberg ticker LABB:MM, develops, sells and markets branded pharmaceutical and personal-care products in Mexico and internationally.